Alyftrek

Active Ingredient(s): Deutivacaftor + Tezacaftor + Vanzacaftor Calcium
FDA Approved: * December 20, 2024
Pharm Company: * VERTEX PHARMS INC
Category: Genetic Disorders
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Alyftrek Oral Tablet, Film Coated
NDC: 51167-121
Labeler:
Vertex Pharmaceuticals Incorporated
Alyftrek Oral Tablet, Film Coated
NDC: 51167-135
Labeler:
Vertex Pharmaceuticals Incorporated